NL8901655A - Werkwijze voor het filmcoaten van farmaceutische preparaten met polymeerdispersies. - Google Patents
Werkwijze voor het filmcoaten van farmaceutische preparaten met polymeerdispersies. Download PDFInfo
- Publication number
- NL8901655A NL8901655A NL8901655A NL8901655A NL8901655A NL 8901655 A NL8901655 A NL 8901655A NL 8901655 A NL8901655 A NL 8901655A NL 8901655 A NL8901655 A NL 8901655A NL 8901655 A NL8901655 A NL 8901655A
- Authority
- NL
- Netherlands
- Prior art keywords
- coating
- film
- coating liquid
- xanthan gum
- aqueous
- Prior art date
Links
- 239000006185 dispersion Substances 0.000 title claims description 41
- 239000007888 film coating Substances 0.000 title claims description 28
- 238000009501 film coating Methods 0.000 title claims description 28
- 238000000034 method Methods 0.000 title claims description 22
- 229920000642 polymer Polymers 0.000 title claims description 18
- 239000000825 pharmaceutical preparation Substances 0.000 title description 2
- 238000000576 coating method Methods 0.000 claims description 81
- 239000011248 coating agent Substances 0.000 claims description 71
- 239000007788 liquid Substances 0.000 claims description 50
- 229920001285 xanthan gum Polymers 0.000 claims description 33
- 239000000230 xanthan gum Substances 0.000 claims description 32
- 235000010493 xanthan gum Nutrition 0.000 claims description 32
- 229940082509 xanthan gum Drugs 0.000 claims description 32
- 239000000463 material Substances 0.000 claims description 27
- 239000000049 pigment Substances 0.000 claims description 26
- 239000004816 latex Substances 0.000 claims description 22
- 229920000126 latex Polymers 0.000 claims description 22
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 15
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 14
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 239000000454 talc Substances 0.000 claims description 12
- 229910052623 talc Inorganic materials 0.000 claims description 12
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 10
- 229920001577 copolymer Polymers 0.000 claims description 10
- 239000000178 monomer Substances 0.000 claims description 9
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 8
- 239000004815 dispersion polymer Substances 0.000 claims description 6
- 239000004408 titanium dioxide Substances 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 239000002245 particle Substances 0.000 description 13
- 238000003756 stirring Methods 0.000 description 12
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 10
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 10
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 10
- 239000011343 solid material Substances 0.000 description 9
- 210000004211 gastric acid Anatomy 0.000 description 7
- 238000004062 sedimentation Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 229920003134 Eudragit® polymer Polymers 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000015271 coagulation Effects 0.000 description 4
- 238000005345 coagulation Methods 0.000 description 4
- GDCRSXZBSIRSFR-UHFFFAOYSA-N ethyl prop-2-enoate;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCOC(=O)C=C GDCRSXZBSIRSFR-UHFFFAOYSA-N 0.000 description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 4
- -1 polyoxyethylene Polymers 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000006255 coating slurry Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 229920003161 Eudragit® RS 30 D Polymers 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000003405 delayed action preparation Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000007720 emulsion polymerization reaction Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000004922 lacquer Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000007971 pharmaceutical suspension Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- KGYXYKHTHJPEBX-UHFFFAOYSA-N 5-ethoxy-3-ethoxycarbonyl-3-hydroxy-5-oxopentanoic acid Chemical compound CCOC(=O)CC(O)(CC(O)=O)C(=O)OCC KGYXYKHTHJPEBX-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229920003163 Eudragit® NE 30 D Polymers 0.000 description 1
- 229920003157 Eudragit® RL 30 D Polymers 0.000 description 1
- 229920003151 Eudragit® RL polymer Polymers 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 235000000380 Nyssa aquatica Nutrition 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- ZAFFWOKULJCCSA-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate;trimethylazanium;chloride Chemical compound [Cl-].C[NH+](C)C.CCOC(=O)C(C)=C ZAFFWOKULJCCSA-UHFFFAOYSA-N 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229960004667 ethyl cellulose Drugs 0.000 description 1
- 229920006228 ethylene acrylate copolymer Polymers 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- DNKKLDKIFMDAPT-UHFFFAOYSA-N n,n-dimethylmethanamine;2-methylprop-2-enoic acid Chemical compound CN(C)C.CC(=C)C(O)=O.CC(=C)C(O)=O DNKKLDKIFMDAPT-UHFFFAOYSA-N 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- VBSPHZOBAOWFCL-UHFFFAOYSA-N setastine Chemical compound C=1C=CC=CC=1C(C=1C=CC(Cl)=CC=1)(C)OCCN1CCCCCC1 VBSPHZOBAOWFCL-UHFFFAOYSA-N 0.000 description 1
- 229950003911 setastine Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000007939 sustained release tablet Substances 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D133/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Coating compositions based on derivatives of such polymers
- C09D133/04—Homopolymers or copolymers of esters
- C09D133/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, the oxygen atom being present only as part of the carboxyl radical
- C09D133/08—Homopolymers or copolymers of acrylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU334688 | 1988-06-29 | ||
| HU883346A HU202120B (en) | 1988-06-29 | 1988-06-29 | Process for film coating of medical compositions with polymer dispersions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8901655A true NL8901655A (nl) | 1990-01-16 |
Family
ID=10963667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8901655A NL8901655A (nl) | 1988-06-29 | 1989-06-29 | Werkwijze voor het filmcoaten van farmaceutische preparaten met polymeerdispersies. |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPH0248521A (da) |
| AT (1) | AT400297B (da) |
| CH (1) | CH678917A5 (da) |
| DE (1) | DE3921403A1 (da) |
| FR (1) | FR2633517B1 (da) |
| GB (1) | GB2220142B (da) |
| HU (1) | HU202120B (da) |
| IT (1) | IT1230167B (da) |
| NL (1) | NL8901655A (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10260919A1 (de) * | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug |
| DE10260921A1 (de) * | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zum Überziehen von Substraten für pharmazeutische Anwendungen mit einem Gemisch aus zwei filmbildenden Überzugsmitteln |
| DE10260920A1 (de) * | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von Arnzeiformen oder Nahrungsergänzungsmitteln mit pigmentierten Polymerüberzügen |
| JP7459796B2 (ja) * | 2018-09-28 | 2024-04-02 | 日本ゼオン株式会社 | 重合体ラテックスおよび積層体 |
| EP3981849A4 (en) | 2019-06-07 | 2023-06-07 | Nippon Soda Co., Ltd. | WET COATING AGENT FOR FINE PARTICLES |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3981984A (en) * | 1968-04-01 | 1976-09-21 | Colorcon Incorporated | Color film coating of tablets and the like |
| US3663284A (en) * | 1970-01-09 | 1972-05-16 | Marine Colloids Inc | Titanium dioxide suspensions |
| US4652313A (en) * | 1984-10-24 | 1987-03-24 | Crompton And Knowles Corporation | Aqueous lake pigment suspension |
| ZA86252B (en) * | 1985-01-30 | 1986-09-24 | Warner Lambert Co | Coated dosage forms |
| CH666405A5 (de) * | 1985-06-24 | 1988-07-29 | Ciba Geigy Ag | Feste, haltbare darreichungsformen mit elastischem filmueberzug. |
| JPS62125847A (ja) * | 1985-11-27 | 1987-06-08 | クロンプトン・アンド・ノウルス・コ−ポレ−シヨン | 薄塗り技術に有用な水性二酸化チタン懸濁物 |
| DE3600576A1 (de) * | 1986-01-10 | 1987-07-16 | Stotmeister Gmbh | Pulveriges beschichtungsmaterial zum beschichten von baustoffen |
| FR2595249B1 (fr) * | 1986-03-10 | 1989-12-01 | Univ Victor Segalen Bordeaux 2 | Composition pharmaceutique consistant en une suspension de carbonate de calcium |
| US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
-
1988
- 1988-06-29 HU HU883346A patent/HU202120B/hu not_active IP Right Cessation
-
1989
- 1989-06-27 CH CH2388/89A patent/CH678917A5/de not_active IP Right Cessation
- 1989-06-29 GB GB8914906A patent/GB2220142B/en not_active Expired - Lifetime
- 1989-06-29 JP JP1165510A patent/JPH0248521A/ja active Pending
- 1989-06-29 AT AT0159989A patent/AT400297B/de not_active IP Right Cessation
- 1989-06-29 FR FR898908680A patent/FR2633517B1/fr not_active Expired - Lifetime
- 1989-06-29 NL NL8901655A patent/NL8901655A/nl not_active Application Discontinuation
- 1989-06-29 IT IT8921024A patent/IT1230167B/it active
- 1989-06-29 DE DE3921403A patent/DE3921403A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| GB2220142B (en) | 1991-09-04 |
| AT400297B (de) | 1995-11-27 |
| CH678917A5 (da) | 1991-11-29 |
| FR2633517B1 (fr) | 1990-12-07 |
| FR2633517A1 (fr) | 1990-01-05 |
| HU202120B (en) | 1991-02-28 |
| ATA159989A (de) | 1995-04-15 |
| IT8921024A0 (it) | 1989-06-29 |
| IT1230167B (it) | 1991-10-14 |
| HUT52965A (en) | 1990-09-28 |
| JPH0248521A (ja) | 1990-02-19 |
| GB8914906D0 (en) | 1989-08-23 |
| DE3921403A1 (de) | 1990-02-08 |
| GB2220142A (en) | 1990-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5723151A (en) | Cellulose acetate phthalate enteric coating compositions | |
| US5851579A (en) | Aqueous enteric coating compositions | |
| EP0648487A1 (en) | Dispersion of enteric coating agent | |
| US4287221A (en) | Method for providing enteric coating on solid dosage forms | |
| US4462839A (en) | Enteric coating for pharmaceutical dosage forms | |
| Ichikawa et al. | Use of ion-exchange resins to prepare 100 μm-sized microcapsules with prolonged drug-release by the Wurster process | |
| CA1199869A (en) | Preparation of aqueous alcoholic dispersions of ph sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same | |
| US6183783B1 (en) | Method for preparing microcapsules comprising active materials coated with a polymer and novel microcapsules in particular obtained according to the method | |
| US5750148A (en) | Method for preparing solid enteric pharmaceutical preparation | |
| US4452862A (en) | Pharmaceutical coating materials soluble or swellable in gastric juice and pharmaceutical dosage forms coated therewith | |
| NO161124B (no) | Polymerpulver for aa danne et enterisk belegg paa farmasoeytiske doseringsformer, og fremgangsmaate for fremstilling derav. | |
| El‐Samaligy et al. | Polyalkyl cyanoacrylate nanocapsules | |
| JPH0881392A (ja) | 薬剤形状物用被覆剤及び結合剤及び薬剤形状物 | |
| FR2498084A1 (fr) | Procede de preparation de microcapsules | |
| JPH09501947A (ja) | 改良された錠剤コーティング方法 | |
| EP0662323B1 (en) | Method for preparing aqueous emulsion for coating solid pharmaceutical preparations | |
| NL8901655A (nl) | Werkwijze voor het filmcoaten van farmaceutische preparaten met polymeerdispersies. | |
| Chang et al. | Preparation and evaluation of shellac pseudolatex as an aqueous enteric coating system for pellets | |
| KR100420269B1 (ko) | 무용매로코팅된고형제제및그후처리방법 | |
| Narisawa et al. | An organic acid-induced sigmoidal release system for oral controlled-release preparations. III. Elucidation of the anomalous drug release behavior through osmotic pumping mechanism | |
| Weiβ et al. | Simple coacervation of hydroxypropyl methylcellulose phthalate (HPMCP) II. Microencapsulation of ibuprofen | |
| US20040228916A1 (en) | Pharmaceutical solid preparation containing a poorly soluble drug and production process thereof | |
| Chang et al. | Preparation and preliminary evaluation of Eudragit RL and RS pseudolatices for controlled drug release | |
| Bando et al. | Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit® S100: L100 dispersion | |
| Yüksel et al. | Preparation of polymeric microspheres by the solvent evaporation method using sucrose stearate as a droplet stabilizer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BV | The patent application has lapsed |